Pre-infection neutralizing antibodies, Omicron BA.5 breakthrough infection, and long COVID: a propensity score-matched analysis

Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Yusuke Oshiro, Natsumi Inamura, Takashi Nemoto, Junko S. Takeuchi, Yunfei Li, Maki Konishi, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Shinichi Oka, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
doi: https://doi.org/10.1101/2023.04.05.23288162

Article Information

doi 
https://doi.org/10.1101/2023.04.05.23288162
History 
  • April 6, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Shohei Yamamoto, Ph.D.1,*,†,
  2. Kouki Matsuda, Ph.D.2,3,4,
  3. Kenji Maeda, M.D., Ph.D.4,5,
  4. Kumi Horii, R.N.6,
  5. Kaori Okudera, R.N.7,
  6. Yusuke Oshiro, M.T.8,
  7. Natsumi Inamura, M.T.8,
  8. Takashi Nemoto, M.T.8,
  9. Junko S. Takeuchi, Ph.D.9,
  10. Yunfei Li, Ph.D.1,
  11. Maki Konishi1,
  12. Kiyoto Tsuchiya, Ph.D.2,
  13. Hiroyuki Gatanaga, M.D., Ph.D.2,
  14. Shinichi Oka, M.D., Ph.D.2,
  15. Tetsuya Mizoue, M.D., Ph.D.1,
  16. Haruhito Sugiyama, M.D., Ph.D.10,
  17. Nobuyoshi Aoyanagi, M.D., Ph.D.11,
  18. Hiroaki Mitsuya, M.D.,Ph.D.5,
  19. Wataru Sugiura, M.D., Ph.D.12 and
  20. Norio Ohmagari, M.D., Ph.D.13
  1. 1Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
  2. 2AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan
  3. 3Japan Foundation for AIDS Prevention, Tokyo, Japan
  4. 4Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan
  5. 5Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan
  6. 6Infection Control Office, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan
  7. 7Infection Control Office, Kohnodai Hospital of the National Center for the Global Health and Medicine, Chiba, Japan
  8. 8Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan
  9. 9Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
  10. 10Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan
  11. 11Kohnodai Hospital of the National Center for the Global Health and Medicine, Chiba, Japan
  12. 12Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
  13. 13Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
  1. ↵†Corresponding Author:
    Shohei Yamamoto, Ph.D., Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan; email: syamamoto{at}hosp.ncgm.go.jp
Back to top
Posted April 06, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Pre-infection neutralizing antibodies, Omicron BA.5 breakthrough infection, and long COVID: a propensity score-matched analysis
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Yusuke Oshiro, Natsumi Inamura, Takashi Nemoto, Junko S. Takeuchi, Yunfei Li, Maki Konishi, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Shinichi Oka, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
medRxiv 2023.04.05.23288162; doi: https://doi.org/10.1101/2023.04.05.23288162
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area